Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • Education • BioTech • Retail (& E-Commerce) • Cosmetics (& Fashion) • HealthTech (& Fitness) • Gaming (& eSports) • Food & Beverage • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer |
Stages | Pre-Seed, Seed, Early Stage |
Investing | United States • Canada |
Investment Range | $25,000 - $500,000 |
Investment Sweet Spot | $200,000 |
CentreGold Capital is a venture capital firm specializing in early-stage investments, focusing primarily on consumer marketplaces and digital health startups in North America and China. They are interested in technologies or tech-enabled business models that advance healthcare and consumer sectors, particularly in food and e-commerce. CentreGold Capital is sector-focused, which allows the firm to support its portfolio companies within an ecosystem and leverage unique market insights and a global network. They offer extensive assistance to early-stage startups to define and refine go-to-market strategies, acquire customers, create suited operating models, fundraise, and more. Their investment philosophy recognizes the changing contemporary lifestyle and the high-growth demands for personalized products and services that promote consumer well-being. This includes clean foods, sustainable personal finance, and convenient healthcare. CentreGold Capital believes that data-driven technologies are essential complements to fulfilling these demands. With investment specialties in Pre-Seed, Seed, and Early Stage rounds, CentreGold Capital typically invests between $25,000 and $500,000, with a sweet spot of around $200,000. The sectors they invest in include Software, Education, BioTech, Retail & E-Commerce, Cosmetics & Fashion, HealthTech & Fitness, Gaming & eSports, Food & Beverage, Medical Devices & Hospital Services, Healthcare & Wellness, Consumer, and other related areas. They are driven by a mission to invest for better living of all mankind, supporting visionary entrepreneurs with innovative solutions to improve quality of life. The firm is not interested in sector-agnostic AI/ML or deep tech with long R&D cycles.